European Companies Search Engine
EU funding (€2,185,740): Biomarker Applications for Nanotechnology and Imaging in Diabetes /Piap-GA-2011-286386 Urosense Fts1 Jan 2012 Financial Transparency System
Overview
Text
Project
| Subject of Grant or Contract | BIOMARKER APPLICATIONS FOR NANOTECHNOLOGY AND IMAGING IN DIABETES /PIAP-GA-2011-286386 UROSENSE |
| Responsible Department | REA - European Research Executive Agency |
| Programme Name | 1.1.1 - Seventh Research framework programme (including sixth Research framework programme) |
| Type of Contract* | Action Grant |
| Reference of the Legal Commitment (LC) | SRCS I2.129722 |
| Management Type | Direct management |
| Geographical Zone | - |
| Budget | BGUE |
| Action Location | - |
| Commitment Total Amount (EUR) (A+B) | 2,185,740.00 |
| Project end Date | 31/12/2015 |
| Commitment Contracted Amount (EUR) (A) | 2,482,306.00 |
| Budget Line Name | People |
| Funding Type | Grant |
| Additional/Reduced Amount (EUR) (B) | -296,566.00 |
| Year | 2011 |
| Reference (Budget) | CPM.286386-708201.1 |
| Commitment Consumed Amount (EUR) | 2,185,740.00 |
| Budget Line Number | 15 07 77 |
| Project Start Date | 01/01/2012 |
| Expense Type | Operational |
Beneficiaries
-
Coordinator No Address VAL FLEURI 84 Beneficiary’s Contracted Amount (EUR) 454,700.00 Beneficiary’s Estimated Contracted Amount (EUR) 400,376.09 Postal Code 1526 Beneficiary Country Luxembourg Beneficiary’s Estimated Consumed Amount (EUR) 400,376.09 VAT Number of Beneficiary LU14472612 Beneficiary Group Code LRCS E04 Not-for-Profit Organisation (Nfpo) No Beneficiary Type Public Bodies Name of Beneficiary CENTRE DE RECHERCHE PUBLIC DE LA SANTE*CRP SANTE NUTS2 Luxembourg City LUXEMBOURG Non-Governmental Organisation (NGO) No -
Coordinator Yes Address GLASNEVIN Beneficiary’s Contracted Amount (EUR) 764,262.00 Beneficiary’s Estimated Contracted Amount (EUR) 672,954.11 Postal Code 0009 Beneficiary Country Ireland Beneficiary’s Estimated Consumed Amount (EUR) 672,954.11 VAT Number of Beneficiary IRCS E6517957E Beneficiary Group Code LRCS E04 Not-for-Profit Organisation (Nfpo) No Beneficiary Type Public Bodies Name of Beneficiary DUBLIN CITY UNIVERSITY*DCU NUTS2 - City DUBLIN Non-Governmental Organisation (NGO) No -
Coordinator No Address HUSBYBORG Beneficiary’s Contracted Amount (EUR) 463,426.00 Beneficiary’s Estimated Contracted Amount (EUR) 408,059.58 Postal Code 752 29 Beneficiary Country Sweden Beneficiary’s Estimated Consumed Amount (EUR) 408,059.58 VAT Number of Beneficiary SRCS E556193784701 Beneficiary Group Code LRCS E05 Not-for-Profit Organisation (Nfpo) No Beneficiary Type Private Companies Name of Beneficiary GEMS PET SYSTEMS AKTIEBOLAG* NUTS2 Ostra Mellansverige City UPPSALA Non-Governmental Organisation (NGO) No -
Coordinator No Address SHENZHOU ROAD 8 ACADEMIC CITY Beneficiary’s Contracted Amount (EUR) 306,826.00 Beneficiary’s Estimated Contracted Amount (EUR) 270,168.89 Postal Code 501660 Beneficiary Country China Beneficiary’s Estimated Consumed Amount (EUR) 270,168.89 VAT Number of Beneficiary CN440101726823380 Beneficiary Group Code LRCS E05 Not-for-Profit Organisation (Nfpo) No Beneficiary Type Private Companies Name of Beneficiary GUANGZHOU KONCEN BIOSCIENCE CO LTD* NUTS2 - City GUANGZHOU Non-Governmental Organisation (NGO) No -
Coordinator No Address VIA DE GRASSI GIOVANNINO 11 Beneficiary’s Contracted Amount (EUR) 493,092.00 Beneficiary’s Estimated Contracted Amount (EUR) 434,181.32 Postal Code 20123 Beneficiary Country Italy Beneficiary’s Estimated Consumed Amount (EUR) 434,181.32 VAT Number of Beneficiary IT04227720960 Beneficiary Group Code LRCS E05 Not-for-Profit Organisation (Nfpo) No Beneficiary Type Private Companies Name of Beneficiary ???HIS SPA*???NUTS2 Lombardia City MILANO Non-Governmental Organisation (NGO) No
The filing refers to a past date, and does not necessarily reflect the current state.
The visualizations for "CRP Sante - EU funding (€2,185,740): Biomarker Applications for Nanotechnology and Imaging in Diabetes /Piap-GA-2011-286386 Urosense"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
